Champions Oncology, Inc. (CSBR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 15.04M | 13.99M | 12.36M | 17.04M | 13.49M | 14.06M | 14M | 12.02M | 11.57M | 12.56M | 13.07M | 12.77M | 14.28M | 13.74M | 12.88M | 13.19M | 11.79M | 11.25M | 10.56M |
| Revenue Growth % | -100% | 11.46% | -0.47% | -11.76% | 41.77% | 16.56% | 11.94% | 7.12% | -5.9% | -18.96% | -8.61% | 1.51% | -3.18% | 21.17% | 22.15% | 21.88% | 22.02% | 16.5% | 17.87% | 20.74% |
| Cost of Goods Sold | 8.83M | 7.62M | 8.35M | 7.67M | 7.01M | 7.83M | 7.52M | 7.25M | 7.85M | 6.62M | 7.68M | 7.34M | 7.7M | 7.44M | 7.05M | 6.22M | 6.41M | 5.61M | 5.4M | 5.65M |
| COGS % of Revenue | - | 50.68% | 59.69% | 62.04% | 41.17% | 58.03% | 53.49% | 51.78% | 65.3% | 57.18% | 61.17% | 56.14% | 60.28% | 52.12% | 51.31% | 48.31% | 48.56% | 47.59% | 47.95% | 53.51% |
| Gross Profit | -8.83M | 7.42M | 5.64M | 4.69M | 10.02M | 5.66M | 6.54M | 6.75M | 4.17M | 4.96M | 4.88M | 5.73M | 5.07M | 6.84M | 6.69M | 6.66M | 6.79M | 6.18M | 5.86M | 4.91M |
| Gross Margin % | - | 49.32% | 40.31% | 37.96% | 58.83% | 41.97% | 46.51% | 48.22% | 34.7% | 42.82% | 38.83% | 43.86% | 39.72% | 47.88% | 48.69% | 51.69% | 51.44% | 52.41% | 52.05% | 46.49% |
| Gross Profit Growth % | -188.13% | 30.98% | -13.73% | -30.53% | 140.38% | 14.27% | 34.1% | 17.76% | -17.82% | -27.54% | -27.13% | -13.87% | -25.24% | 10.7% | 14.27% | 35.5% | 9.66% | 38.1% | 39.09% | 30.67% |
| Operating Expenses | 8M | 7.23M | 6.15M | 6.4M | 5.53M | 4.93M | 5.21M | 6.59M | 6.75M | 6.91M | 7.43M | 7.45M | 7.53M | 6.83M | 6.98M | 6.97M | 5.96M | 5.91M | 6.03M | 5.37M |
| OpEx % of Revenue | - | 48.09% | 43.94% | 51.83% | 32.43% | 36.55% | 37.06% | 47.05% | 56.14% | 59.71% | 59.14% | 56.97% | 58.97% | 47.83% | 50.76% | 54.1% | 45.15% | 50.18% | 53.6% | 50.81% |
| Selling, General & Admin | 5.64M | 4.97M | 4.07M | 4.44M | 3.81M | 3.24M | 3.76M | 4.54M | 4.56M | 4.39M | 4.64M | 4.59M | 4.33M | 4.23M | 4.09M | 4.38M | 3.78M | 3.62M | 3.73M | 3.3M |
| SG&A % of Revenue | - | 33.07% | 29.06% | 35.95% | 22.34% | 24.03% | 26.72% | 32.41% | 37.95% | 37.98% | 36.91% | 35.15% | 33.9% | 29.6% | 29.76% | 33.99% | 28.62% | 30.67% | 33.13% | 31.22% |
| Research & Development | 2.27M | 2.62M | 2.08M | 1.96M | 1.72M | 1.69M | 1.45M | 2.05M | 2.19M | 2.52M | 2.79M | 2.85M | 3.2M | 2.6M | 2.89M | 2.59M | 2.18M | 2.3M | 2.3M | 2.07M |
| R&D % of Revenue | - | 17.4% | 14.88% | 15.89% | 10.09% | 12.52% | 10.34% | 14.63% | 18.19% | 21.73% | 22.24% | 21.82% | 25.07% | 18.23% | 21% | 20.11% | 16.53% | 19.51% | 20.47% | 19.59% |
| Other Operating Expenses | 89K | -357K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -276K | 185K | -507K | -1.71M | 4.5M | 732K | 1.33M | 164K | -2.58M | -1.96M | -2.55M | -1.71M | -2.46M | 7K | -284K | -311K | 830K | 263K | -175K | -456K |
| Operating Margin % | - | 1.23% | -3.62% | -13.87% | 26.4% | 5.43% | 9.45% | 1.17% | -21.44% | -16.89% | -20.32% | -13.11% | -19.24% | 0.05% | -2.07% | -2.42% | 6.29% | 2.23% | -1.56% | -4.32% |
| Operating Income Growth % | -106.13% | -74.73% | -138.15% | -1145.12% | 274.58% | 137.44% | 152.08% | 109.57% | -4.84% | -28028.57% | -798.59% | -451.13% | -396.14% | -97.34% | -62.29% | 31.8% | -15.48% | 3657.14% | -829.17% | 72.26% |
| EBITDA | -276K | 542K | -149K | -1.32M | 4.9M | 1.13M | 1.78M | 621K | -2.1M | -1.47M | -2.11M | -996K | -1.61M | 840K | 513K | 508K | 1.24M | 883K | 387K | 19K |
| EBITDA Margin % | - | 3.6% | -1.06% | -10.68% | 28.74% | 8.38% | 12.64% | 4.44% | -17.44% | -12.71% | -16.77% | -7.62% | -12.59% | 5.88% | 3.73% | 3.94% | 9.41% | 7.49% | 3.44% | 0.18% |
| EBITDA Growth % | -105.64% | -52.08% | -108.38% | -312.56% | 333.64% | 176.89% | 184.39% | 162.35% | -30.35% | -275.12% | -510.72% | -296.06% | -229.47% | -4.87% | 32.56% | 2573.68% | -12.9% | 91.96% | 65.38% | 101.47% |
| D&A (Non-Cash Add-back) | 0 | 357K | 358K | 394K | 398K | 399K | 449K | 457K | 481K | 484K | 445K | 718K | 850K | 833K | 797K | 819K | 412K | 620K | 562K | 475K |
| EBIT | 0 | 255K | -452K | -1.96M | 4.52M | 739K | 1.33M | -191K | -2.52M | -2.06M | -2.54M | -2.54M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K | -449K |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -584K | 0 | -9K | -18K | 0 | -32K | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 584K | 0 | 9K | 18K | 0 | 32K | 0 | 0 | 0 |
| Other Income/Expense | 39K | 70K | 55K | -250K | 19K | 7K | 5K | -355K | 58K | -105K | 14K | -827K | 36K | -9K | -18K | -35K | -32K | 26K | 17K | 7K |
| Pretax Income | -237K | 255K | -452K | -1.96M | 4.52M | 739K | 1.33M | -191K | -2.52M | -2.06M | -2.54M | -2.54M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K | -449K |
| Pretax Margin % | - | 1.7% | -3.23% | -15.9% | 26.52% | 5.48% | 9.49% | -1.36% | -20.96% | -17.8% | -20.21% | -19.44% | -18.96% | -0.01% | -2.2% | -2.69% | 6.05% | 2.45% | -1.4% | -4.25% |
| Income Tax | 42K | 18K | 14K | -129K | 23K | 11K | 21K | -82K | 11K | 11K | 28K | 20K | 17K | 14K | 17K | -2K | 11K | 12K | 14K | 32K |
| Effective Tax Rate % | -17.72% | 7.06% | -3.1% | 6.57% | 0.51% | 1.49% | 1.57% | 42.93% | -0.44% | -0.53% | -1.1% | -0.79% | -0.7% | -700% | -5.63% | 0.58% | 1.38% | 4.15% | -8.86% | -7.13% |
| Net Income | -279K | 299K | -436K | -1.83M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K | -481K |
| Net Margin % | - | 1.99% | -3.12% | -14.84% | 26.38% | 5.4% | 9.34% | -0.78% | -21.05% | -17.9% | -20.43% | -19.59% | -19.1% | -0.11% | -2.32% | -2.67% | 5.97% | 2.35% | -1.53% | -4.55% |
| Net Income Growth % | -106.21% | -58.93% | -133.21% | -1582.57% | 277.67% | 135.15% | 151.17% | 95.74% | -3.73% | -12843.75% | -704.39% | -644.48% | -409.91% | -105.78% | -85.47% | 28.48% | 6.35% | 27600% | -329.33% | 77.27% |
| Net Income (Continuing) | -279K | 237K | -466K | -1.83M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K | -481K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 95K | 61K | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02 | 0.02 | -0.03 | -0.13 | 0.31 | 0.05 | 0.09 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | -0.00 | -0.02 | -0.03 | 0.05 | 0.02 | -0.01 | -0.04 |
| EPS Growth % | -106.45% | -64.35% | -133.8% | - | 263.16% | 134.6% | 149.21% | 95.79% | -5.56% | - | -705.08% | -645.1% | -429.07% | -106.32% | -84.38% | 28.97% | -17.25% | - | - | 77.56% |
| EPS (Basic) | -0.02 | 0.02 | -0.03 | -0.13 | 0.33 | 0.05 | 0.10 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | -0.00 | -0.02 | -0.03 | 0.06 | 0.02 | -0.01 | -0.04 |
| Diluted Shares Outstanding | 13.89M | 14.46M | 13.79M | 13.75M | 14.36M | 14.02M | 14.04M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.56M | 13.53M | 13.52M | 13.51M | 14.39M | 14.55M | 13.4M | 13.4M |
| Basic Shares Outstanding | 13.89M | 13.79M | 13.79M | 13.75M | 13.7M | 13.59M | 13.59M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.55M | 13.53M | 13.52M | 13.28M | 13.5M | 13.43M | 13.4M | 13.4M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |